Skip to main content
Equibles
LAB logo

LAB · Standard Biotools Inc. · Webcasts, Transcripts & Audio

Track LAB — free

Use LAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.77 +0.03 (+3.40%)
Rebalance outlook locked
Market Cap
$290.47M
Shares
392.58M
Volume · Oct 5 466.74K Avg daily vol (3M) 1.68M

Standard Biotools Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Standard Biotools Inc. (LAB), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼28.5% $28.50M −$13.84M '21 Q3 21-11-08 ▼14.2% $38.27M −$9.43M '21 Q4 22-02-18 ▼19.2% $26.50M −$76.29M '22 Q1 22-05-05 ▼39.5% $18.78M −$63.54M '22 Q2 22-08-08 ▼10% $25.65M −$29.43M '22 Q3 22-11-08 ▼29.4% $27.02M −$20.84M '22 Q4 23-01-09 ▼5.2% $25.12M −$16.84M '23 Q1 23-05-09 ▲47.3% $27.67M −$17.04M '23 Q2 23-08-08 ▼1.1% $25.37M −$21.00M '23 Q3 23-11-07 ▲4.3% $28.19M −$19.78M '23 Q4 24-01-08 ▲81.3% $45.54M −$32.16M '24 Q1 24-03-31 ▼18.7% $22.49M −$45.72M '24 Q2 24-07-31 ▼12.9% $22.09M −$26.94M '24 Q3 24-10-30 ▼96.8% $890,000 −$34.07M '24 Q4 25-01-13 ▼55.6% $20.22M −$26.03M '25 Q1 25-05-06 LATEST ▼3.2% $21.76M −$33.46M '25 Q2 25-08-11
Earnings call
FY25 · Q2
2025-08-11
Standard Biotools Inc. (LAB) Q2 2025 Earnings Call
Revenue
$21.76M
▼ 3.2% YoY
Diluted EPS
$-0.09
Gross margin
48.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Standard Biotools Inc. (LAB) Q1 2025 Earnings Call Transcript
Revenue
$20.22M
▼ 55.6% YoY
Diluted EPS
$-0.07
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Standard Biotools Inc. (LAB) Q4 2024 Earnings Call Transcript
Positive tone SomaLogic Integration & SomaScan Macro/Policy Backdrop Risk China Market & Geopolitics
Revenue
$890,000*
▼ 96.8% YoY
Gross margin
-202.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Standard Biotools Inc. (LAB) Q3 2024 Earnings Call Transcript
Positive tone Consumables growth Geographic performance including China Revenue guidance reiteration and 2025 outlook
Revenue
$22.09M
▼ 12.9% YoY
Diluted EPS
$-0.07
Gross margin
54.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Standard Biotools Inc. (LAB) Q2 2024 Earnings Call Transcript
Positive tone Illumina partnership and NovaSeq platform Leadership transition (CFO departure) SomaScan services and customer concentration
Revenue
$22.49M
▼ 18.7% YoY
Diluted EPS
$-0.12
Gross margin
46.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Standard Biotools Inc. (LAB) Q1 2024 Earnings Call Transcript
Positive tone Illumina NGS partnership SomaScan assay and proteomics growth SomaLogic integration and synergies
Revenue
$45.54M
▲ 81.3% YoY
Diluted EPS
$-0.27
Gross margin
53.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Standard Biotools Inc. (LAB) Q4 2023 Earnings Call Transcript
Confident tone SomaLogic merger and integration Product portfolio and technology platforms Revenue growth and 2024 guidance
Revenue
$28.19M*
▲ 4.3% YoY
Gross margin
47.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Standard Biotools Inc. (LAB) Q3 2023 Earnings Call Transcript
Revenue
$25.37M
▼ 1.1% YoY
Diluted EPS
$-0.27
Gross margin
44.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Standard Biotools Inc. (LAB) Q2 2023 Earnings Call Transcript
Revenue
$27.67M
▲ 47.3% YoY
Diluted EPS
$-0.22
Gross margin
49.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Standard Biotools Inc. (LAB) Q1 2023 Earnings Call Transcript
Revenue
$25.12M
▼ 5.2% YoY
Diluted EPS
$-0.21
Gross margin
48.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Standard Biotools Inc. (LAB) Q4 2022 Earnings Call Transcript
Revenue
$27.02M*
▼ 29.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Standard Biotools Inc. (LAB) Q3 2022 Earnings Call Transcript
Revenue
$25.65M
▼ 10% YoY
Diluted EPS
$-0.37
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Standard Biotools Inc. (LAB) Q2 2022 Earnings Call Transcript
Revenue
$18.78M
▼ 39.5% YoY
Diluted EPS
$-0.82
Gross margin
23.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Standard Biotools Inc. (LAB) Q1 2022 Earnings Call Transcript
Revenue
$26.50M
▼ 19.2% YoY
Diluted EPS
$-0.99
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Standard Biotools Inc. (LAB) Q4 2021 Earnings Call
Revenue
$38.27M*
▼ 14.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Standard Biotools Inc. (LAB) Q3 2021 Earnings Call Transcript
Revenue
$28.50M
▼ 28.5% YoY
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Standard Biotools Inc. (LAB) Q2 2021 Earnings Call Transcript
Revenue
$31.02M
▲ 19% YoY
Diluted EPS
$-0.23
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Standard Biotools Inc. (LAB) Q1 2021 Earnings Call Transcript
Revenue
$32.79M
▲ 18.7% YoY
Diluted EPS
$-0.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-10
Standard Biotools Inc. (LAB) Q4 2020 Earnings Call Transcript
Revenue
$44.61M
▲ 37.5% YoY
Gross margin
49.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Standard Biotools Inc. (LAB) Q3 2020 Earnings Call Transcript
Revenue
$39.86M
▲ 50.4% YoY
Diluted EPS
$-0.08
Gross margin
52.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Standard Biotools Inc. (LAB) Q2 2020 Earnings Call Transcript
Revenue
$26.06M
▼ 7.6% YoY
Diluted EPS
$-0.18
Gross margin
45.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Standard Biotools Inc. (LAB) Q1 2020 Earnings Call Transcript
Revenue
$27.62M
▼ 8.3% YoY
Gross margin
47.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-14
Standard Biotools Inc. (LAB) Q4 2019 Earnings Call
Revenue
$32.44M
▲ 0.4% YoY
Gross margin
54.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–23 of 23 webcasts
Key facts CIK 1162194 CUSIP 34385P108 13F (30d) 1 filings 1 filers Visit website Investor relations